Showing results (2181-2190 of 2,722) with videos related to

Sort By:
Pageof 273
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 4, 2018
Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized TrialsSukhdeep Bhogal, Hemang B Panchal, Jayant Bagai, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 27, 2017
Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stentDeborah N Kalkman, Pier Woudstra, Ian B A Menown, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 25, 2013
Endovascular treatment of acute limb ischemia and proximal deep vein thrombosis using rotational thrombectomy: A review of published literatureMichael Lichtenberg, Friedrich-Wilhelm Stahlhoff, Dirk Boese
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 1, 2013
Impact of thrombus aspiration during primary percutaneous coronary intervention in cardiogenic shock complicating ST-segment elevation myocardial infarctionFrancesco Tomassini, Andrea Gagnor, Nicolò Montali, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 10, 2021
A Case of Ruptured Giant Sinus of Valsalva Aneurysm Into the Right Ventricle in a Patient With Both Atrial and Ventricular Septal DefectsMohammed Mhanna, Azizullah Beran, Zeid Nesheiwat, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 20, 2021
Gender difference in outcomes of patients undergoing MitraClip therapy: A systematic review and meta-analysisChanavuth Kanitsoraphan, Sittinun Thangjui, Chol Techorueangwiwat, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 2, 2022
Do Patients With Non-Viable Myocardium From Ischemic Cardiomyopathy Benefit From Revascularization? A Systematic Review And Meta-AnalysisFarideh Davoudi, Satoshi Miyashita, Tae Kyung Yoo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2022
Additive Effect of Multiple High-Risk Coronary Artery Segments on Patient Outcomes: LRP Study Sub-AnalysisBrian C Case, Rebecca Torguson, Gary S Mintz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 1, 2022
Network Meta-Analysis Comparing the Short- and Long-Term Outcomes of Alternative Access for Transcatheter Aortic Valve ReplacementSagar Ranka, Shubham Lahan, Adnan K Chhatriwalla, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 3, 2022
An Opportunity to Improve Secondary Prevention With Icosapent Ethyl in Patients Who Have Undergone Coronary Artery Bypass Graft SurgeryNick S R Lan, Umar S Ali, Robert Larbalestier, et al.
Pageof 273